South Korean solar inverter makers have jointly launched a new association of inverter manufacturers to coordinate domestic production, safeguard local expertise, and address import-driven market ...
The new 12.5 kWh pack-based design supports flexible configuration up to 250 kWh per system. An optional long-duration combiner box supports 2–4 clusters, expandable to 1,000 kWh and 8 hours of ...
Zacks Investment Research on MSN
FDA Greenlights Novartis' Gene Replacement Treatment for SMA
Novartis NVS obtained FDA approval for onasemnogene abeparvovec-brve, a gene replacement therapy, for children two years and ...
Itvisma contains the active ingredient in Zolgensma approved in 2019 for children younger than 2 years but is reformulated ...
Onasemnogene abeparvovec-brve is the first gene replacement therapy approved for SMA patients aged 2 years and older, expanding access beyond infants. Phase 3 trials demonstrated significant motor ...
Zelestra has signed a PPA with technology giant Microsoft to sell power generated at a 95.7MW solar PV portfolio.
A next-generation treatment from Novo Nordisk helped patients with diabetes lower their blood sugar and lose weight in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback